Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Stopped early · Phase 2

Conditions studied: Type 2 Diabetes Mellitus

In brief

The purpose of this study is to demonstrate that dutogliptin/PHX1149T is safe and tolerable.

Key facts

Study ID

NCT01101945

Run by

Phenomix

People needed

339

Starts

2007-07-01

Expected to finish

2010-03-01

Last updated by the study team

2010-08-11

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completed Visit 7/Day 98 of the core protocol PHX1149-PROT202
• Current treatment of Type 2 diabetes mellitus in accordance with product labeling with metformin, or thiazolidinedione (TZD), or metformin + TZD

You may not qualify if…

• Inadequately controlled Type 2 diabetes mellitus with need for therapy with insulin

Where it is running

• Study site — Long Beach, California, United States
• Study site — Orange, California, United States
• Study site — San Diego, California, United States
• Study site — Kissimmee, Florida, United States
• Study site — Melbourne, Florida, United States
• Study site — New Port Richey, Florida, United States
• Study site — Gurnee, Illinois, United States
• Study site — Wichita, Kansas, United States
• Study site — Kansas City, Missouri, United States
• Study site — Henderson, Nevada, United States
• Study site — Las Vegas, Nevada, United States
• Study site — Berlin, New Jersey, United States
• Study site — Margate City, New Jersey, United States
• Study site — Trenton, New Jersey, United States
• Study site — Charlotte, North Carolina, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Oklahoma City, Oklahoma, United States
• Study site — Medford, Oregon, United States
• Study site — Warminster, Pennsylvania, United States
• Study site — Columbia, South Carolina, United States
• Study site — Greer, South Carolina, United States
• Study site — Dallas, Texas, United States
• Study site — San Antonio, Texas, United States
• Study site — Fullerton, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.